1 In this context,
we developed a novel 384-multiwell microelectrode array (MMEA
2 To address this,
we developed a novel adeno-associated virus (AAV-GLP-1R) that
3 of co-expression cannot cope with this level of complexity,
we developed a novel algorithm called DynOmics.
4 Here,
we developed a novel alignment-free method, ChimeRScope that
5 We developed a novel analytical framework for mapping and tes
6 Here,
we developed a novel and simple strategy to greatly enhance t
7 To resolve unanswered questions about these inhibitors,
we developed a novel approach to map the distribution of func
8 We developed a novel approach towards the identification of a
9 mbining nanoscopy with epi-mark textural image informatics,
we developed a novel approach, termed EDICTS (Epi-mark Descri
10 To investigate this claim,
we developed a novel assay that allows for parallel profiling
11 To address this,
we developed a novel auditory feature-selective attention tas
12 n-associated effects in mice generalize to another species,
we developed a novel Bace1(-/-) rat line using zinc-finger nu
13 To address these issues, herein
we developed a novel carrier-free theranostic system with nan
14 To examine this hypothesis,
we developed a novel computational method to assess the biolo
15 We developed a novel formulation and a computationally effici
16 We developed a novel hand-rearing paradigm in European starli
17 To this end,
we developed a novel hydrosoluble zwitterionic MMP inhibitor,
18 We developed a novel learning algorithm, called pre-condition
19 We developed a novel local alignment vector analysis method t
20 We developed a novel mathematical model explicitly considerin
21 We developed a novel method and ultra-fast software Findr for
22 We developed a novel method for delivering anti-miRs using li
23 r to fully exploit the potential of SSRs as genetic marker,
we developed a novel method for SSR genotyping, named as AmpS
24 In this work,
we developed a novel method to achieve the multichannel optic
25 We developed a novel method to compute gene-level P-values (f
26 Taking Boston as an illustrative Northeast U.S. city,
we developed a novel method to estimate sub-urban, food-borne
27 We developed a novel method, PyroTyping, for discrimination o
28 We developed a novel methodology for burden estimation and pr
29 To minimize the side effects,
we developed a novel microneedle array (MNA) that could deliv
30 We developed a novel mirror box illusion to investigate wheth
31 he importance of the raft environment on prion propagation,
we developed a novel model for prion infection where cells ex
32 We developed a novel model of cancer-induced BTP using female
33 Here,
we developed a novel model to test the hypothesis that cell-t
34 In conclusion,
we developed a novel mouse model of PBC that may help to eluc
35 We developed a novel mouse strain in which the human low-affi
36 Herein,
we developed a novel nitrogen-doped carbonaceous nanosphere c
37 Here,
we developed a novel receptor-ligand model of the adenosine s
38 We developed a novel redundant-relevant learning paradigm to
39 We developed a novel reporter assay that enabled identificati
40 We developed a novel score to predict posttransplant outcomes
41 By taking advantage of certain features in piperidine 4,
we developed a novel series of cyclohexylamine- and piperidin
42 s are less representative of community exposure; therefore,
we developed a novel spatial phytosampling methodology to stu
43 We developed a novel stimulus that can be adjusted parametric
44 We developed a novel system for direct and online characteriz
45 Here,
we developed a novel task to explore how people adjust effort
46 We developed a novel tetravalent dengue vaccine by using viru
47 We developed a novel tool, the Curacao Long-Term Chikungunya
48 Therefore,
we developed a novel two-level contingency change task in whi
49 In this work,
we developed a novel type of Beynon Gabor zone plate based on
50 Here
we developed a novel whole-body insertional mutagenesis scree